Skyrizi IV Injection 600mg, manufactured by AbbVie, contains Risankizumab (genetical recombination) (YJ code: 3999450A1025, 600mg 10mL bottle). This interleukin-23 (IL-23) inhibitor is used to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis in adults.
Skyrizi IV Injection 600mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →